SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024161
Filing Date
2022-11-10
Accepted
2022-11-10 07:30:54
Documents
97
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q itrm-20220930.htm   iXBRL 10-Q 3773591
2 EX-10.1 itrm-ex10_1.htm EX-10.1 254417
3 EX-10.2 itrm-ex10_2.htm EX-10.2 328742
4 EX-10.3 itrm-ex10_3.htm EX-10.3 282699
5 EX-31.1 itrm-ex31_1.htm EX-31.1 22186
6 EX-31.2 itrm-ex31_2.htm EX-31.2 22559
7 EX-32.1 itrm-ex32_1.htm EX-32.1 13471
8 EX-32.2 itrm-ex32_2.htm EX-32.2 13463
  Complete submission text file 0000950170-22-024161.txt   15756387

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itrm-20220930_lab.xml EX-101.LAB 636286
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itrm-20220930_pre.xml EX-101.PRE 524366
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itrm-20220930.xsd EX-101.SCH 90077
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itrm-20220930_def.xml EX-101.DEF 364967
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itrm-20220930_cal.xml EX-101.CAL 58796
91 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20220930_htm.xml XML 3256019
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 221374951
SIC: 2834 Pharmaceutical Preparations